FDA reviews contraceptive device after health complaints

Thousands of women say they've been harmed by the permanent contraceptive, but it's still unclear if the problems were caused by the device.

The FDA is looking into the contraceptive device, Essure, after a number of health complaints.

Some of those complaints include chronic fatigue, migraines, joint pain, digestive issues, back pain, heavy periods full of clots, difficulty concentrating, abdominal pain, hair loss and tooth deterioration, according to NPR. But, it is not clear if the problems were caused by the device. 

Thousands of women say they've been harmed by the permanent contraceptive Essure. But it's unclear if the problems were caused by the device. The Food and Drug Administration is taking a closer look.

Read More at NPR

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground